• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • AbbVie and Calibr partner to develop T-cell therapies for cancer pharmaceutical-technology
    June 28, 2018
    AbbVie has formed an alliance with Scripps Research’s non-profit drug discovery unit Calibr to develop next-generation T-cell therapies that are aimed at targeting various cancers, including solid tumours.
  • GSK makes T-cell move pharmatimes
    September 11, 2017
    GSK has exercised its option to exclusively license the right to research, develop, and commercialise Adaptimmune's NY-ESO SPEAR T-cell therapy programme, from a collaboration and license agreement signed in 2014.
  • Artificial T-cell receptors market pharmaasia
    July 04, 2017
    Futuristic application of Therapeutics expecting 44% CAGR during 2016-2023: Occams Business Research & Consulting Pvt. Ltd.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service